YFYing Fu

Ying Fu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ying Fu has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Chun‐Lai Jiang

    National Engineering Laboratory for AIDS Vaccine, School of Life Sciences, Jilin University, Changchun, China

    1 shared publication
  • Huiyan Wang

    Jilin Medical University, Jilin Collaborative Innovation Center for Antibody Engineering, Jilin 132013, China,(H.W.), China

    1 shared publication
  • Jia‐Qi Zhang

    Jilin Medical University, Jilin, China

    1 shared publication
  • Qinying Ma

    Department of Psychiatry, The First Hospital of Hebei Medical University, Shijiazhuang, China

    1 shared publication
  • Yaqi Sun

    Department of Psychiatry, The First Hospital of Hebei Medical University, Shijiazhuang, China

    1 shared publication
  • Yayun Tian

    Department of Psychiatry, The First Hospital of Hebei Medical University, Shijiazhuang, China

    1 shared publication

Latest Publications

  • Open Access

    Case Report: Insulinoma Presenting as Excessive Daytime Somnolence

    by Zhennan Yu, Yongliang Wang, Yaqi Sun, Yumei Wang, Yayun Tian, Qinying Ma, Ying Fu

    Currently, undiagnosed insulinomas remain a difficult clinical dilemma because its symptoms in most cases can easily be misdiagnosed as other diseases. In this article, we present the case of a 14-year-old girl who presented to our hospital with recurrent episodes of excessive daytime sleepiness and abnormal behavior during sleep that had been going on for 3 months. Insulinoma is a rare neuroendocrine tumor that causes excessive release of insulin, resulting in episodes of hypoglycemia. It usually manifests as autonomic sympathetic symptoms. These symptoms resolved rapidly with the administration of glucose. After successful removal of the tumor, daytime sleepiness and abnormal nighttime behavior of the patient did not reappear.


  • Identification of a missense mutation causing exon skipping in a neurofibromatosis type 1 patient

    by Ying Fu, Jia‐Qi Zhang, Chun‐Lai Jiang, Hui‐Yan Wang

    Neurofibromatosis type 1 (NF1), caused by germ line mutations of the NF1 tumor‐suppressor gene, is one of the most common autosomal dominant disorders. Here, we reported a NF1 patient with the mutation NF1 c.4367+1G>C. This sequence change locates at the first nucleotide of NF1 intron 32 within the consensus splice site. Compared with NF1 c.4367G>C predicted to potentially damage the wild‐type donor site at c.4367, the NF1 c.4367+1G>C potentially abolishes this wild‐type donor site by in silico analysis. In vitro minigene assay revealed that the NF1 c.4367+1G>C may cause exon 32 skipping. Our result provides further evidence for its clinical significance of NF1 c.4367+1G>C in clinical practise.